| A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. T Uchiyama, S Broder, TA Waldmann Journal of immunology (Baltimore, Md.: 1950) 126 (4), 1393-1397, 1981 | 1678 | 1981 |
| A humanized antibody that binds to the interleukin 2 receptor. C Queen, WP Schneider, HE Selick, PW Payne, NF Landolfi, JF Duncan, ... Proceedings of the National Academy of Sciences 86 (24), 10029-10033, 1989 | 1473 | 1989 |
| The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design TA Waldmann Nature Reviews Immunology 6 (8), 595-601, 2006 | 1465 | 2006 |
| Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells CA Klebanoff, L Gattinoni, P Torabi-Parizi, K Kerstann, AR Cardones, ... Proceedings of the national academy of sciences 102 (27), 9571-9576, 2005 | 1211 | 2005 |
| Structure of the human immunoglobulin μ locus: characterization of embryonic and rearranged J and D genes JV Ravetch, U Siebenlist, S Korsmeyer, T Waldmann, P Leder Cell 27 (3), 583-591, 1981 | 1201 | 1981 |
| IL-15Rα recycles and presents IL-15 in trans to neighboring cells S Dubois, J Mariner, TA Waldmann, Y Tagaya Immunity 17 (5), 537-547, 2002 | 1144 | 2002 |
| Metabolism of immunoglobulins TA Waldmann, W Strober, RM BLAESE Progress in immunology, 891-903, 1971 | 1099 | 1971 |
| Molecular cloning and expression of cDNAs for the human interleukin-2 receptor WJ Leonard, JM Depper, GR Crabtree, S Rudikoff, J Pumphrey, RJ Robb, ... Nature 311 (5987), 626-631, 1984 | 1089 | 1984 |
| A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor WJ Leonard, JM Depper, T Uchiyama, KA Smith, TA Waldmann, ... Nature 300 (5889), 267-269, 1982 | 1084 | 1982 |
| Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics R Schmitz, RM Young, M Ceribelli, S Jhavar, W Xiao, M Zhang, G Wright, ... Nature 490 (7418), 116-120, 2012 | 1012 | 2012 |
| Immunotherapy: past, present and future TA Waldmann Nature medicine 9 (3), 269-277, 2003 | 958 | 2003 |
| Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome: evidence for a selective defect in soluble antigen recognition HC Lane, JM Depper, WC Greene, G Whalen, TA Waldmann, AS Fauci New England Journal of Medicine 313 (2), 79-84, 1985 | 924 | 1985 |
| The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens TA Waldmann, Y Tagaya Annual review of immunology 17 (1), 19-49, 1999 | 900 | 1999 |
| Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. M Krönke, WJ Leonard, JM Depper, SK Arya, F Wong-Staal, RC Gallo, ... Proceedings of the National Academy of Sciences 81 (16), 5214-5218, 1984 | 863 | 1984 |
| Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia TA Waldmann, S Broder, RM Blaese, M Durm, M Blackman, W Strober The Lancet 304 (7881), 609-613, 1974 | 830 | 1974 |
| Monoclonal antibodies in diagnosis and therapy TA Waldmann Science 252 (5013), 1657-1662, 1991 | 808 | 1991 |
| Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms A Arnold, J Cossman, A Bakhshi, ES Jaffe, TA Waldmann, SJ Korsmeyer New England Journal of Medicine 309 (26), 1593-1599, 1983 | 764 | 1983 |
| Dynamic, yet structured: the cell membrane three decades after the Singer–Nicolson model G Vereb, J Szöllősi, J Matko, P Nagy, T Farkas, L Vigh, L Matyus, ... Proceedings of the national academy of sciences 100 (14), 8053-8058, 2003 | 756 | 2003 |
| Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human … KC Conlon, E Lugli, HC Welles, SA Rosenberg, AT Fojo, JC Morris, ... Journal of clinical oncology 33 (1), 74-82, 2015 | 741 | 2015 |
| Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis B Bielekova, M Catalfamo, S Reichert-Scrivner, A Packer, M Cerna, ... Proceedings of the National Academy of Sciences 103 (15), 5941-5946, 2006 | 733 | 2006 |
